Eisai Europe Limited (“Eisai”) has developed and funded this website to help distribute the EpiTrack® and EpiTrack® Junior tests to HCPs involved in the management of patients with epilepsy within the countries listed below. Prof. Dr. Christoph Helmstaedter developed and owns the intellectual property rights in the EpiTrack® and EpiTrack® Junior tests. Eisai is the exclusive licensee of the EpiTrack® and EpiTrack® Junior tests in the countries listed below, and the use of the EpiTrack® and EpiTrack® Junior tests is subject to the licence conditions set out in this website.
Welcome to the EpiTrack website
By entering this site you are confirming that you are a doctor, nurse, psychologist or other healthcare professional (HCP) involved in the management of people with epilepsy.
Eisai are working to improve access to EpiTrack® around the world, free of charge for the benefit of the neurology community. Currently we distribute in:
- Czech Republic
- New Zealand
- Republic of Cyprus
- United Kingdom
Please fill out the form if your region is not listed and you would like to register interest
EMEA-EPI-23-00029 | Date of Preparation: August 2023.
This EpiTrack website
is intended for HCPs only
EpiTrack is a clinical tool designed to be used by doctors, nurses, psychologists and other healthcare professionals. . Click here to close.